GL1X · GenesisL1 explorer

MolNFT v1 · #37026 · protein

Organization of the SH3-SH2 unit in active and inactive forms of the C-abl tyrosine kinase

2FO0 · Proto-oncogene tyrosine-protein kinase ABL1 (1B isoform): “Organization of the SH3-SH2 unit in active and inactive forms of the C-abl tyrosine kinase”. X-ray diffraction, 2 ligands (MYR, P16), 9 pockets (best druggability 0.76).…

PDB
2FO0
Type
protein
Length
466 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase ABL1 (1B isoform)
EC
2.7.1.112
Ligands
MYR, P16
Pockets
9 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase ABL1 (1B isoform) (EC 2.7.1.112)protein46632% helix, 23% strand—

Ligands and binding sites

  • MYR · Myristic acid · ligand · chains A
  • P16 · 6-(2,6-dichlorophenyl)-2-{[3-(hydroxymethyl)phenyl]amino}-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19600.760.7976empty
21890.750.9026P16
31070.590.8620MYR
42660.540.7640empty
5780.470.8319empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 2FO0 · Organization of the SH3-SH2 Unit in Active and Inactive Forms of the c-Abl Tyrosine Kinase · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.